了解心力衰竭护理的障碍 (UNLOCK-HF):在喀拉拉邦的一项融合并行混合方法研究
Gautam Satheesh1,2, Rupasvi Dhurjati1, Jaison Joseph1
1The George Institute for Global Health, Hyderabad, India.
Tropical medicine & international health : TM & IH
|December 10, 2025
概括
最佳的心力衰竭 (HF) 护理受到印度喀拉拉邦药品供应不足和高成本的阻碍. 解决这些障碍需要协调卫生系统的努力,以获得公平的患者结果.
科学领域:
- 心脏病学 心脏病学
- 医疗保健服务研究 医疗服务研究
- 公共卫生 公共卫生
背景情况:
- 心力衰竭 (HF) 是一个重大的全球健康挑战,在低收入和中等收入国家中患病率不断上升.
- 对指南推的护理的不理想采用有助于高发病率,死亡率和与HF相关的医疗保健费用.
- 印度喀拉拉邦面临着心血管疾病的高负担,需要了解HF护理障碍.
研究的目的:
- 调查印度喀拉拉邦最佳心力衰竭护理的具体障碍.
- 识别HF治疗和诊断的可用性,负担能力和可访问性方面的挑战.
主要方法:
- 采用了融合的并行混合方法研究.
- 从30家药房收集了关于药物的可用性和定价的数据.
- 与患者,护理人员,医生和政策制定者的采访探索了HF预防,诊断和治疗的障碍.
主要成果:
- 在政府药房中,HF药物的平均可用性为45%,在私人药房中为66%.
- 可负担性差异很大,私营部门的诊断和程序对低工资工人来说特别昂贵.
- 采访强调了医疗保健的碎片化,计划的整合性差,以及意识差距是关键问题.
结论:
- 实现最佳心力衰竭护理的关键障碍包括药品供应不足,负担能力差以及医疗保健服务分散.
- 涉及所有卫生系统利益相关者的协调,多层次的方法对于改善公平有效的HF护理至关重要.
相关概念视频
Coronary Artery Disease V: Interprofessional Care
203
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
203
Heart Failure VII: Nursing Interventions
396
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
396
Heart Failure I: Introduction
660
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
660
Methods of Documentation VI: Case Management Model
837
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
837
Pathophysiology of Heart Failure
2.7K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.7K
Heart Failure V: Medical Management
198
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
198


